Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

1477.HK Gross Margin

The Gross Margin of Ocumension Therapeutics (1477.HK) is 53.93%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

1477.HK Gross Margin - Historical Value
Date Value
2024-12-31 53.93%
2023-12-31 58.60%
2022-12-31 64.74%
2021-12-31 65.78%
2020-12-31 86.84%
2019-12-31 94.74%
2018-12-31 94.74%
1477.HK Gross Margin - Peers Comparison
Ticker Name Value
300436.SZ Fujian Cosunter Pharmaceutical Co Ltd 54.20%
600851.SS Shanghai Haixin Group Co Ltd 53.14%
605199.SS Hainan Huluwa Pharmaceutical Group Co Ltd 47.37%
002099.SZ Zhejiang Hisoar Pharmaceutical Co Ltd 18.31%
300573.SZ Shenyang Xingqi Pharmaceutical Co Ltd 78.16%
300723.SZ ApicHope Pharmaceutical Co Ltd 60.37%
300765.SZ CSPC Innovation Pharmaceutical Co Ltd 41.83%
603439.SS Guizhou Sanli Pharmaceutical Co Ltd 69.43%
603590.SS Beijing Konruns Pharmaceutical Co Ltd 89.02%
688526.SS Wuhan Keqian Biology Co Ltd 62.40%
300497.SZ Jiangxi Fushine Pharmaceutical Co Ltd 8.72%
688513.SS Chengdu Easton Biopharmaceuticals Co Ltd 79.78%
002287.SZ Tibet Cheezheng Tibetan Medicine Co Ltd 82.05%
300401.SZ Zhejiang Garden Biopharmaceutical Co Ltd 58.25%
300630.SZ Hainan Poly Pharm Co Ltd 72.65%
605116.SS Aurisco Pharmaceutical Co Ltd 55.31%
300119.SZ Tianjin Ringpu Bio-Technology Co Ltd 40.73%
688098.SS Shanghai Shen Lian Biomedical Corp 60.25%
002275.SZ Guilin Sanjin Pharmaceutical Co Ltd 72.18%
688189.SS Hunan Nucien Pharmaceutical Co Ltd 51.05%
688356.SS Jenkem Technology Co Ltd 79.00%
688505.SS Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 91.05%
603566.SS Pulike Biological Engineering Inc 60.99%
603520.SS Zhejiang Starry Pharmaceutical Co Ltd 23.12%
603229.SS Zhejiang Ausun Pharmaceutical Co Ltd 53.05%
603718.SS Shanghai Hile Bio-Technology Co Ltd 58.50%
688321.SS Shenzhen Chipscreen Biosciences Co Ltd 86.71%
300705.SZ Hunan Jiudian Pharmaceutical Co Ltd 73.01%